Veeva Systems (VEEV) Stock Slides After Strong Q3 Earnings and Guidance Raise – What’s Really Spooking Investors on 21 November 2025
Veeva Systems shares fell about 9% to $245–246 on Friday despite Q3 revenue rising 16% to $811.2 million and a raised full-year outlook. Wall Street focused on customer losses in Veeva’s CRM business, with Salesforce taking six of the top 20 pharma clients. Analysts issued mixed notes and price targets following the report.
